Showing results (141-150 of 274) with videos related to
Sort By:
Pageof 28
Urologic Oncology|December 23, 2020
Factors associated with higher prostate biopsy yield: when is software-assisted fusion MRI-targeting necessary?Grant M Henning, Joel M Vetter, Joshua A Sterling, et al.Ergonomics|September 5, 2025
Physiological measurement of situation awareness: a study of the validity of EEG and fNIRS during performance and automation monitoring in a complex taskElena K Festa, Isaac Y Kim, Aaron T Winder, et al.Cancer Science|May 29, 2013
Bone morphogenetic protein-6 induces castration resistance in prostate cancer cells through tumor infiltrating macrophagesGeun Taek Lee, Yeon Suk Jung, Yun-Sok Ha, et al.Urologic Oncology|July 17, 2024
Prostate-specific antigen screening for prostate cancer: Diagnostic performance, clinical thresholds, and strategies for refinementVinaik M Sundaresan, Shayan Smani, Pawel Rajwa, et al.Urologic Oncology|September 9, 2015
Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomyIn Gab Jeong, Daoud Dajani, Mohan Verghese, et al.BJU International|July 5, 2011
Multilocular cystic renal cell carcinoma: clinicopathological features and preoperative prediction using multiphase computed tomographyDalsan You, Myungsun Shim, In Gab Jeong, et al.Journal of Endourology|October 30, 2014
Comparison of Hand-Assisted Laparoscopic vs Robot-Assisted Laparoscopic vs Open Partial Nephrectomy in Patients with T1 Renal MassesKyung-Sik Han, Gee Hyun Song, Dalsan You, et al.Journal of Cancer Research and Clinical Oncology|May 21, 2014
The Choi response criteria for inferior vena cava tumor thrombus in renal cell carcinoma treated with targeted therapyTaekmin Kwon, Jae-Lyun Lee, Jeong Kon Kim, et al.Urologic Oncology|December 16, 2014
Regulatory T cells and TGF-β1 in clinically localized renal cell carcinoma: Comparison with age-matched healthy controlsChoung-Soo Kim, Yunlim Kim, Taekmin Kwon, et al.Journal of Korean Medical Science|March 3, 2015
Is intravesical Bacillus Calmette-Guérin therapy superior to chemotherapy for intermediate-risk non-muscle-invasive bladder cancer? An ongoing debateKyung-Sik Han, Dalsan You, In Gab Jeong, et al.Pageof 28